Bionano announces publication showing utility of optical genome mapping in clinical research of infant & toddler t-all

San diego, aug. 07, 2025 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced a peer-reviewed publication from a team led by manon delafoy from the institut necker enfants malades (inem) and colleagues from multiple french pediatric hematology centers showing how optical genome mapping (ogm) can be used to detect oncogenic structural variants (svs) in clinical research of infant and toddler t-cell acute lymphoblastic leukemia (t-all). the publication shows that ogm can reveal distinct genetic drivers and prognostic subgroups that conventional cytogenetics failed to identify in a retrospective, national cohort of 27 t-all cases of infants and toddlers (
BNGO Ratings Summary
BNGO Quant Ranking